about
Biomarkers for childhood-onset systemic lupus erythematosusCombined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndromeAquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivationApplication of difference gel electrophoresis to the identification of inner medullary collecting duct proteins.Early prediction of acute renal injury using urinary proteomics.Proteomics in renal research.A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS-A pilot study.Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape.LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis.Proteomic strategies and their application in studies of renal function.Serum proteomics for the diagnosis of nephrotic syndrome: is there a ray of hope?Prospects for urinary proteomics: exosomes as a source of urinary biomarkers.Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.Regulation of transport in the connecting tubule and cortical collecting ductUrinary proteomics: a tool to discover biomarkers of kidney diseases.Biomarkers of lupus nephritis determined by serial urine proteomicsBiomarkers and updates on pediatrics lupus nephritis.Challenges of genomics and proteomics in nephrology.High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI).Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy.12. The Urinary Proteomics: A Tool to Discover New and Potent Biomarkers for Kidney Damage.cDNA array identification of genes regulated in rat renal medulla in response to vasopressin infusion.Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance.Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO.Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb.Superoxide dismutase type 1 in monocytes of chronic kidney disease patients.Common sense approaches to urinary biomarker study design.Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.Proteomic approaches in understanding a detected relationship between chemotherapy-induced nephrotoxicity and cell respiration in HK-2 cells.Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
P2860
Q27007470-B745E8C7-59D9-448B-BD75-53407F30378AQ28301617-99F99DBB-15D6-4C30-BEC2-7297AE27317AQ28574015-D9C5A7AE-91C8-401E-87F2-EF3E1530ABBEQ30981095-CF0132E4-ED4B-4B30-A34F-098515C535A4Q33217308-C41E409B-C463-44E5-9FBD-6AEAA59BBCD9Q33263714-01D93A57-35C7-4A10-9961-EED8CBBD31B4Q34383382-3D1B7757-876E-4FDF-A798-AD76DC7C85C0Q34446433-F9FFB653-C902-4C77-AE0A-AB51D7161FC1Q34480669-E91BB215-4803-4AC5-82EB-9A8FD3785F60Q35054853-BCF661E3-1069-4DB6-8445-76E3998FF96AQ35641886-3833339F-60B3-4A64-8023-6182BE2C8524Q35773139-4E7C4590-22AC-41FE-B599-54BC257810F6Q35993234-A8D6F29C-B70C-4AFB-B610-17ABAC3F9620Q36164076-372F8A1D-0170-4863-9CE0-BECE401E10B0Q36184802-820D859D-DD69-42ED-89AD-6490AEAF5FBDQ36450027-4ECFFA29-2953-4C50-AE15-82BC209B16F1Q36731380-42F7E16D-9AB4-44FD-8BB6-FE3525A2E092Q37038307-73D7034D-682B-477E-9EFF-8FE6F3873824Q37167062-5A50A4CE-3C02-4756-89A6-5E55925F8305Q37611029-2B3CB064-3C0E-4607-A20E-1DFC60D019C3Q38934802-C0628072-1E6E-43CA-8232-D4E82A53ADE7Q39388008-00CF485A-9015-4219-957C-B5426FD0C409Q41858062-EA8DE321-6599-4587-A66B-11AEA4118D56Q44185804-987B8764-A3B8-4324-AF87-2061BDE338E8Q44294577-C4EE811F-CED8-4508-B1FC-0B19A6AFDB8FQ44499353-FFCD87B8-79F5-4F88-A539-9659DEDC6E6FQ44869351-BA6B915B-97C2-4E44-BCEB-836C7866478DQ45916695-BF780761-DE4A-449D-9511-A2B8C064F244Q47723130-A2159B5C-B79B-423A-9037-3D61B1CCAFD4Q50908478-5B7422CB-0E6B-4043-8F37-5E18CE0E8754Q53241728-F8FB62D9-3C69-4D35-80DF-244F461A9863Q53589016-0B46DBC5-ECFA-4EC3-AE8D-FC9CF7EC2699
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proteomics and the kidney.
@ast
Proteomics and the kidney.
@en
Proteomics and the kidney.
@nl
type
label
Proteomics and the kidney.
@ast
Proteomics and the kidney.
@en
Proteomics and the kidney.
@nl
prefLabel
Proteomics and the kidney.
@ast
Proteomics and the kidney.
@en
Proteomics and the kidney.
@nl
P1476
Proteomics and the kidney.
@en
P2093
Mark A Knepper
P304
P356
10.1097/01.ASN.0000014782.37591.C7
P577
2002-05-01T00:00:00Z